HB 3454 Illinois House · 104th Regular Session

EPINEPHRINE DELIVERY DEVICE

Summary

Amends various Acts to change references from "epinephrine auto-injector" or "epinephrine injector" to "FDA approved epinephrine delivery device or product". Changes the name of the Epinephrine Injector Act to the FDA Approved Epinephrine Delivery Device or Product Act.

Bill status signed all 5 stages cleared

Introduction

Feb 2026

Committee Review

May 2026

House Passage

May 2026

Senate Passage

May 2026

Signed into Law

Aug 2026

Introduced Feb 26, 2026 Signed Aug 7, 2026

Maddy AI version diff · 2 comparisons

What changed between versions

Engrossed → Enrolled · 3 edits · Aug 7, 2026

MINOR

The bill was finalized as an Enrolled version, replacing the Engrossed draft. The primary substantive change is the replacement of the specific term 'FDA approved epinephrine delivery device or product' with the broader term 'epinephrine delivery system.' This modification expands the scope of the law to cover a wider variety of medical devices, not just those with specific FDA approval, while maintaining the requirement that they be prescribed for use by law enforcement agencies.

Scope change

The bill's scope was broadened by changing the definition of the medical device from one requiring specific FDA approval to a broader category known as an 'epinephrine delivery system.'

DEFINITION

The definition of the medical device was changed from 'FDA approved epinephrine delivery device or product' to 'epinephrine delivery system' in multiple sections, allowing the law to apply to a wider range of auto-injectors.

REQUIREMENT

References to specific FDA approval requirements were removed from training and authorization sections, aligning them with the new broader definition of the device.

TECHNICAL

Minor formatting adjustments were made to the bill header and section numbering to reflect its transition from a draft (Engrossed) to a final (Enrolled) version.

Floor votes · Senate May 28, 2026 · House Feb 25, 2026

How they voted

58–0

Passed

Total votes 58

May 28, 2026

D Democratic39

39 Yea

100% Yea

R Republican19

19 Yea

100% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Aug 7, 2026

Signed into law

Governor Approved

lower

May 31, 2026

Lower · Passed

Passed Both Houses

lower

May 31, 2026

Introduced

Senate Floor Amendment No. 2 House Concurs 116-000-000

lower

May 29, 2026

Lower · Passed

Senate Floor Amendment No. 2 Motion to Concur Recommends Be Adopted Prescription Drug Affordability & Accessibility Committee; 013-000-000

lower

May 29, 2026

Committee

Senate Floor Amendment No. 2 Motion to Concur Rules Referred to Prescription Drug Affordability & Accessibility Committee

lower

May 29, 2026

Committee

Senate Floor Amendment No. 2 Motion to Concur Referred to Rules Committee

lower

May 29, 2026

Introduced

Senate Floor Amendment No. 2 Motion Filed Concur Rep. Joyce Mason

lower

May 28, 2026

Introduced

Placed on Calendar Order of Concurrence Senate Amendment(s) 2

lower

May 28, 2026

Introduced

Arrived in House

lower

May 28, 2026

Amended

Senate Committee Amendment No. 1 Tabled Pursuant to Rule 5-4(a)

upper

May 28, 2026

Upper · Passed

Third Reading - Passed; 059-000-000

upper

May 28, 2026

Upper · Passed

Senate Floor Amendment No. 2 Adopted; Glowiak-Hilton

upper

May 19, 2026

Introduced

Senate Floor Amendment No. 2 Be Approved for Consideration Assignments

upper

May 18, 2026

Committee

Senate Floor Amendment No. 2 Referred to Assignments

upper

May 18, 2026

Introduced

Senate Floor Amendment No. 2 Filed with Secretary by Sen. Suzy Glowiak Hilton

upper

May 6, 2026

Upper · Passed

Do Pass Insurance; 009-000-000

upper

May 6, 2026

Committee

Senate Committee Amendment No. 1 Referred to Assignments

upper

May 6, 2026

Introduced

Senate Committee Amendment No. 1 Filed with Secretary by Sen. Suzy Glowiak Hilton

upper

Apr 28, 2026

Committee

Assigned to Insurance

upper

Mar 26, 2026

Committee

Referred to Assignments

upper

Feb 26, 2026

Introduced

Arrive in Senate

upper

Feb 25, 2026

Lower · Passed

Third Reading - Short Debate - Passed 105-000-000

lower

Feb 11, 2026

Lower · Passed

Approved for Consideration Rules Committee; 005-000-000

lower

Apr 11, 2025

Committee

Rule 19(a) / Re-referred to Rules Committee

lower

Mar 19, 2025

Lower · Passed

Do Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000

lower

Mar 11, 2025

Committee

Assigned to Prescription Drug Affordability & Accessibility Committee

lower

Feb 18, 2025

Committee

Referred to Rules Committee

lower

2 primary · 9 co-sponsors